AXIL vs BIIB · P/E 57, rev $30.8M vs P/E 21, rev $9.89B
AXIL Brands, Inc. (AXIL) versus Biogen Inc (BIIB) — a side-by-side from cached financials, not a winner call.
AXIL Brands, Inc. (AXIL) is a consumer electronics company listed on US.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ. It is led by Christopher A. Viehbacher.
Latest reported AXIL revenue for 2026-05-31 was $30.8M. Net income was $2.7M. Revenue was up 17.5% from 2025-05-31 to 2026-05-31. AXIL currently screens at market cap $46.7M and trailing P/E 57.1.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
AXIL currently screens at market cap $46.7M and trailing P/E 57.1. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Not investment advice. Open the AXIL and BIIB stock pages for the full models.
Not investment advice.